Questcor Pharmaceuticals (NASDAQ:QCOR)

CAPS Rating: 3 out of 5

A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.

Recs

1
Player Avatar Zhuren (97.40) Submitted: 6/3/2009 2:45:49 AM : Outperform Start Price: $4.43 QCOR Score: +794.85

I hate making story stock picks, but this company is still growing, and is committed to shareholder value by buying stock back at these depressed levels. It's bargain priced if you expect its growth to continue, although it is dependent on US customers, which is a big negative in the years to come. But if the growth continues, it will at least kill the returns of the S&P500.

Report this Post Reply

Featured Broker Partners


Advertisement